100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
Antazoline-D5 (HCl Salt)
● Under Development
| Katalog-Nr.:: | DVE002152 |
|---|---|
| CAS-Nr.:: | N/A |
| Summenformel:: | C17H15D5ClN3 |
| Molare Masse:: | 306.84 g/mol |
Zusätzliche Informationen zu
Parent drug
AntazolineIUPAC-Name
4,5-Dihydro-N-phenyl-d5-N-(phenylmethyl)-1H-Imidazole-2-methanamine HydrochloridePharmacopeial Synonyms
N/ASynonyme
N/ASMILES
[2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1N(CC2=CC=CC=C2)CC3=NCCN3.[H]ClInChI
InChI=1S/C17H19N3.ClH/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16;/h1-10H,11-14H2,(H,18,19);1H/i2D,5D,6D,9D,10D;Beschreibung
Antazoline-D5 (HCl Salt) is the deuterated impurity form of antazoline presenting a mass shift of +5 Da and forming the hydrochloride salt. As an isotopic impurity it requires characterization of isotopic enrichment, non-exchangeable versus exchangeable deuterium content, and potential back-exchange during sample preparation. Typical impurity profiling includes LC-MS for retention time separation, high resolution mass spectrometry to confirm mass accuracy, and NMR for deuterium incorporation. Stability studies assess acid or base induced H/D exchange and thermal decomposition. Specifications commonly cover isotopic purity, related substances by LC, water content, residual solvents, and assay to ensure reproducible quantitation in trace-level impurity analysis.Angebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Antazoline impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
Antazoline/ Antazoline Phosphate
CAS No. 154-68-7
Cat No. VE0028333
Antazoline / Antazoline Hydrochloride
CAS No. 2508-72-7
Cat No. VE0027647